Relay Therapeutics, Inc.
NASDAQ:RLAYBiotechnology
Healthcare
$15.91 +2.63%
+$0.41 today
- Market cap
- $3.52B
- Beta
- 1.75
- P/E (TTM)
- -10.5
- EPS (TTM)
- -$1.52
52W Low $3.03High $17.47
Volume 1.88M
Average 3.70M
Price history
Relay Therapeutics, Inc. SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
+150.95%
Period high
$20.75
Period low
$6.34
Latest
$15.91
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| 8-K | Nov 4, 2026 | Nov 4, 2026 | |
| 10-Q | Nov 4, 2026 | Nov 4, 2026 | |
| 4 | Oct 30, 2026 | Oct 30, 2026 | |
| 4 | Oct 30, 2026 | Oct 30, 2026 | |
| 4 | Oct 30, 2026 | Oct 30, 2026 | |
| 4 | Oct 8, 2026 | Oct 8, 2026 | |
| 4 | Oct 8, 2026 | Oct 8, 2026 | |
| 4 | Sep 9, 2026 | Sep 9, 2026 | |
| 4 | Sep 9, 2026 | Sep 9, 2026 | |
| 4 | Sep 9, 2026 | Sep 9, 2026 | |
| 4 | Aug 28, 2026 | Aug 28, 2026 | |
| 4 | Aug 28, 2026 | Aug 28, 2026 | |
| 4 | Aug 18, 2026 | Aug 18, 2026 | |
| 4 | Aug 18, 2026 | Aug 18, 2026 | |
| SC 13G/A | Aug 14, 2026 | Aug 14, 2026 |
Competitors
Who does Relay Therapeutics, Inc. compete with?
Open similar companies to compare their filings and price history.
Competitors
Peer companies in the same sector
Questions
Filing questions
Common questions about RLAY's filings, answered from its disclosures.
What is the latest RLAY filing?
The latest filing shown is 10-Q dated Nov 4, 2026.
How many recent filings does RLAY have?
Intrinsic Alpha currently shows 20 recent filings for RLAY.
Continue the stock analysis
Jump to another research area for this company.